Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05853198
NA
Circulating Tumor DNA as Surgical Biomarker in Patients With PancrEatic Adenocarcinoma for Statement of Resectability
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona
View on ClinicalTrials.gov
Summary
The main objective is the evaluation of the prognostic value of ctDNA (circulating tumor DNA) as a marker of surgical futility in patients with operable PDAC.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
165
Start Date
2022-12-29
Completion Date
2026-05-31
Last Updated
2023-05-10
Healthy Volunteers
No
Conditions
Interventions
OTHER
ctDNA analysis
ctDNA amount and mutations analysis
Locations (1)
AOUI Verona
Verona, Italy